Photobiomodulation with Low-Level Laser Therapy to Treat Rheumatoid Arthritis: Experimental and Clinical Evidence

Authors

  • Sabrina Zanchetta Lanza Programa de P´os-graduação em Ciência Cirúrgica Interdisciplinar, Universidade Federal de São Paulo-EPM, Brazil https://orcid.org/0009-0006-6908-3328
  • Gaspar de Jesus Lopes Filho Programa de P´os-graduação em Ciência Cirúrgica Interdisciplinar, Universidade Federal de São Paulo-EPM, Brazil https://orcid.org/0000-0002-9344-6479
  • Fernando Russo Costa do Bomfim Centro Universitário da Fundação Hermínio Ometto, Brazil https://orcid.org/0000-0002-2614-3603

DOI:

https://doi.org/10.47852/bonviewJOPR52025303

Keywords:

photobiomodulation, arthritis, low-level laser therapy

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease that primarily affects the joints and can cause severe deformities, progressive destruction of joint structures, and significant functional impact. Although several mechanisms are known, the etiology is multifactorial and three times more women than men are affected. In addition to the joints, the disease can affect other systems, causing manifestations such as fatigue, fever, cardiovascular and nephrological changes, which together reduce patients' quality of life. Despite therapeutic advances with immunomodulatory and biological drugs, there are still many limitations, such as adverse effects and insufficient control of disease progression. In this scenario, photobiomodulation (PBM) using low-intensity lasers or LEDs has emerged as a promising complementary therapeutic approach due to its ability to modulate inflammatory processes, relieve pain, and stimulate tissue repair, all in a safe and non-invasive manner. This study aims to evaluate the effects of PBM in the treatment of RA based on a systematic review of the literature, examining the physical aspects of the technique, the pathophysiological mechanisms of RA in humans and in experimental models, and the clinical and experimental evidence related to the efficacy of PBM. The results indicate that PBM works by reducing oxidative stress and promoting tissue regeneration, with significant benefits in controlling inflammation and pain. Recent technological advances in the field of PBM, including more precise and adaptable devices, strengthen its potential as an effective complementary therapy, but challenges remain in terms of standardization of application parameters and clinical validation.

 

Received: 24 January 2025 | Revised: 19 May 2025 | Accepted: 25 June 2025

 

Conflicts of Interest

The authors declare that they have no conflicts of interest to this work.

 

Data Availability Statement

Data sharing is not applicable to this article as no new data were created or analyzed in this study.

 

Author Contribution Statement

Sabrina Zanchetta Lanza: Methodology, Investigation, Writing – original draft, Writing – review & editing, Visualization. Gaspar de Jesus Lopes Filho: Methodology, Writing – review & editing, Supervision, Project administration. Fernando Russo Costa do Bomfim: Conceptualization, Methodology, Validation, Investigation, Writing – original draft, Writing – review & editing, Supervision, Project administration.


Downloads

Published

2025-07-21

Issue

Section

Review

How to Cite

Lanza, S. Z. ., Filho, G. de J. L. ., & Bomfim, F. R. C. do . (2025). Photobiomodulation with Low-Level Laser Therapy to Treat Rheumatoid Arthritis: Experimental and Clinical Evidence. Journal of Optics and Photonics Research. https://doi.org/10.47852/bonviewJOPR52025303